Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950170-25-025021
Filing Date
2025-02-21
Accepted
2025-02-21 17:57:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 8789
2 EX-99.1 ck0001669811-ex99_1.pdf EX-99.1 80981
  Complete submission text file 0000950170-25-025021.txt   122135
Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 646-205-5300
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 1715 38TH ST BOULDER CO 80301
Business Address 1715 38TH ST BOULDER CO 80301 720-262-7002
Edgewise Therapeutics, Inc. (Subject) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92424 | Film No.: 25653499
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)